AI assistant
Sending…
Oaktree Acquisition Corp. III Life Sciences — Director's Dealing 2024
Oct 23, 2024
33469_dirs_2024-10-23_af76da08-ec28-4e4f-b85e-8014838511c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Oaktree Acquisition Corp. III Life Sciences (OACC)
CIK: 0002029769
Period of Report: 2024-10-23
Reporting Person: Kumar Aman (N/A)
More from Oaktree Acquisition Corp. III Life Sciences
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Mar 26
Interim / Quarterly Report
2025
Nov 13
Director's Dealing
2025
Oct 29
Board/Management Information
2025
Oct 29
Director's Dealing
2025
Oct 22
Board/Management Information
2025
Oct 17
Interim / Quarterly Report
2025
Aug 12
Major Shareholding Notification
2025
Jul 15
Director's Dealing
2025
Jun 16